The Lancet Neurology in conversation with
Explore the latest breakthroughs in brain health and neurological disease through interviews with leading researchers, neurologists, and policy experts. Each episode breaks down complex topics for a broad audience, trans...
Insights from recent episode analysis
On the show
- Henry Brodaty1 ep
- Alice Powell1 ep
- Jan Lünemann1 ep
Also: Christian Münz, Hal Dietz, Tony Schapira, Niklas Mattsson-Carlgren, Cristina Tassorelli, Inga Zerr, Simon Mead, Dr Julia Greenland, Ian McKeith, Ask Nordestgaard, Marjo van der Knaap, Clifford Jack, Charlotte Teunissen, Tammie Benzinger, Jonathan Graff-Radford
Audience Interest
Podcast Focus
Publishing Consistency
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Based on 1 signal.
Built from
By chart position
- 🇧🇷Brazil · Medicine#120672 to 3.6K
- 🇹🇷TR · Medicine#60432 to 2.3K
- 🇮🇳India · Medicine#141397 to 2.1K
- 🇯🇵Japan · Medicine#102396 to 2.1K
- 🇳🇴NO · Medicine#12958 to 305
- Per-Episode Audience
Est. listeners per new episode within ~30 days
2.0K to 11K🎙 Monthly cadence·72 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
2.2K to 12K🇺🇸71%🇧🇷10%🇹🇷6%+4 more - Active Followers
Loyal subscribers who consistently listen
894 to 4.7K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 9/9/26 | Alzheimer's diseaseblood biomarkers+4 | Clifford JackCharlotte Teunissen+2 | Mayo ClinicAmsterdam UMC+3 | — | Alzheimer's diseaseblood biomarkers+7 | — | 28m 49s | ||
| 8/12/26 | vanishing white matter diseaseleukodystrophy+4 | Marjo van der Knaap | guanabenzAmsterdam UMC+1 | Amsterdam | vanishing white matterguanabenz+6 | — | 17m 27s | ||
| 7/15/26 | Epstein-Barr virusmultiple sclerosis+3 | Jan LünemannChristian Münz | University of British ColumbiaUniversity of Zürich+3 | — | Epstein-Barr virusmultiple sclerosis+3 | — | 15m 45s | ||
| 6/17/26 | geneticsspinal CSF leaks+5 | Hal Dietz | Johns Hopkins MedicineThe Lancet Neurology+2 | Baltimore, USA | geneticsspinal CSF leaks+7 | — | 16m 23s | ||
| 6/16/26 | GBA1 Parkinson's diseasegenetic links+3 | Tony Schapira | GBA1UCL’s Queen Square Institute of Neurology+1 | — | GBA1Parkinson's disease+5 | — | 26m 05s | ||
| 4/17/26 | cognitive resilienceageing+4 | Henry BrodatyAlice Powell | University of New South WalesThe Lancet Neurology | — | cognitive reservebrain maintenance+5 | — | 23m 11s | ||
| 3/18/26 | biomarkersAlzheimer's disease+3 | Niklas Mattsson-Carlgren | p-tau217eMTBR-tau243+2 | — | biomarkersAlzheimer's disease+3 | — | 16m 06s | ||
| 2/18/26 | migraine preventionCGRP pathway+3 | Cristina Tassorelli | University of PaviaThe Lancet | — | migraineCGRP+5 | — | 24m 01s | ||
| 1/21/26 | prion diseasesgenetic factors+4 | Inga ZerrSimon Mead | DZNEUCL London+1 | — | prion diseasesgenetic factors+4 | — | 30m 11s | ||
| 12/19/25 | Parkinson's diseaseclinical trials+3 | Dr Julia Greenland | azathioprineThe Lancet+1 | — | Parkinson's diseaseazathioprine+3 | — | 15m 06s | ||
| 11/12/25 | dementiaLewy bodies+4 | Ian McKeith | Newcastle University | — | dementiaLewy bodies+5 | — | 16m 54s | ||
| 10/15/25 | stroke riskwomen's health+4 | Ask Nordestgaard | Brigham and Women's HospitalThe Lancet | Boston | strokewomen+5 | — | 11m 48s |
Showing 12 of 72
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for The Lancet Neurology in conversation with
Peaked at #60 in TR, currently #60 in TR.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| TR | — | #60 | #60 | — |
| Japan | — | #102 | #102 | — |
| Brazil | — | #120 | #120 | — |
| CL | — | #120 | #120 | — |
| Norway | — | #129 | #129 | — |
| India | — | #141 | #141 | — |
Chart Positions
6 placements across 6 markets.
Chart Positions
6 placements across 6 markets.